| <img alt="" height="1" width="1" />News and FDA Updates for Salix (NASDAQ:SLXP), Enzo (NYSE:ENZ), Lannett (NYSE:LCI)American Chronicle... the Company´s proposed new drug application (NDA) for rifaximin in the treatment of patients with non-constipation irritable bowel syndrome (non-C IBS). ...<nobr>and more »</nobr> |
Google- News and FDA Updates for Salix (NASDAQ:SLXP), Enzo (NYSE:ENZ), Lannett (NYSE:LCI) - American Chronicle
1 - 1 of 1 Posts
1 - 1 of 1 Posts
- This is an older thread, you may not receive a response, and could be reviving an old thread. Please consider creating a new thread.
Join the discussion
Irritable Bowel Syndrome and Digestive Health Support Forum
A forum community dedicated to Irritable Bowel Syndrome and Digestive Health Support. Come join the discussion about treatment, diet, health, lifestyles, spirituality, medication, research, recovery, and more!
Full Forum Listing
Recommended Communities
Join now to ask and comment!